Alborz Bulk Pharmaceutical Raw Materials Company (DBALK)
- Ticker
- DBALK
- Industry
- Pharmaceuticals
- Market
- Iran Fara Bourse
Line of business
Establishing every kind of factory for the synthesis and production of every kind of medicine and raw material; producing and selling pharmaceutical products and dosage forms; and selling pharmaceutical raw materials
Latest trading day
Date: October 25, 2026
- Closing price
- 17,460 rials
- Change on the previous close
- -3.00%
- Volume
- 13,664,703 shares
- Trade value
- 23.86 billion tomans
- Market cap
- 3,178 billion tomans
DBALK returns against the market, the dollar and gold
Up to the stock's last trade on October 25, 2026. Each row runs from the last price before the period starts to the latest price, and the stock's return is adjusted for capital raises and cash dividends. The indexes come from the Tehran Stock Exchange (TSETMC); the free-market dollar and 18k gold are daily free-market prices in tomans.
| Series | 1 month |
|---|---|
| DBALK | 18.1% |
| Bourse total index | 12.6% |
| Farabourse total index | 17.1% |
| Free-market dollar | 15.2% |
| 18k gold (per gram) | 7.4% |
Weekly, 3-month, 1-year and 5-year returns, and the comparison with the industry, the Emami gold coin, the world gold ounce and Tehran housing, are on Fundai with free sign-up.
Key figures
| Item | Value | Basis |
|---|---|---|
| P/E TTM | 10.66 | Report to 1405/06/31 |
| P/B | 5.54 | Report to 1405/06/31 |
| Gross margin TTM | 31.6% | Report to 1405/06/31 |
| Net margin TTM | 15.8% | Report to 1405/06/31 |
| ROE TTM | 52.0% | Report to 1405/06/31 |